Overall, regarding the percentage of signal-positive tumours (IRS ≥ 3) (Figure 9A) and the extent of expression (Figure 9B), GPR68 was most prominently expressed in neuroendocrine tumours from the pancreas, followed by those from the rectum or gut and typical carcinoids of the lung. Here, GPR68 is linked to neoplasm.